Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.72 - $1.66 $25,824 - $59,540
35,868 New
35,868 $54,000
Q2 2023

Aug 11, 2023

BUY
$1.79 - $4.59 $32,807 - $84,125
18,328 Added 63.73%
47,088 $84,000
Q4 2022

Aug 11, 2023

SELL
$2.48 - $5.93 $644 - $1,541
-260 Reduced 0.9%
28,760 $97,000
Q4 2022

Feb 13, 2023

SELL
$2.48 - $5.93 $644 - $1,541
-260 Reduced 0.9%
28,760 $97,000
Q3 2022

Aug 11, 2023

SELL
$4.08 - $5.82 $3,292 - $4,696
-807 Reduced 2.71%
29,020 $158,000
Q3 2022

Nov 03, 2022

SELL
$4.08 - $5.82 $3,292 - $4,696
-807 Reduced 2.71%
29,020 $158,000
Q2 2022

Aug 11, 2023

BUY
$4.15 - $8.37 $1,365 - $2,753
329 Added 1.12%
29,827 $134,000
Q2 2022

Aug 15, 2022

BUY
$4.15 - $8.37 $1,365 - $2,753
329 Added 1.12%
29,827 $135,000
Q1 2022

Aug 11, 2023

BUY
$5.91 - $14.38 $4,361 - $10,612
738 Added 2.57%
29,498 $217,000
Q1 2022

May 20, 2022

SELL
$5.91 - $14.38 $52,025 - $126,587
-8,803 Reduced 22.98%
29,498 $217,000
Q4 2021

Feb 16, 2022

SELL
$5.21 - $8.61 $4,543 - $7,507
-872 Reduced 2.23%
38,301 $246,000
Q3 2021

Nov 12, 2021

SELL
$4.45 - $10.63 $4,423 - $10,566
-994 Reduced 2.47%
39,173 $228,000
Q2 2021

Aug 12, 2021

SELL
$8.11 - $11.11 $5,393 - $7,388
-665 Reduced 1.63%
40,167 $415,000
Q1 2021

May 03, 2021

SELL
$9.85 - $17.69 $246 - $442
-25 Reduced 0.06%
40,832 $430,000
Q4 2020

Feb 12, 2021

BUY
$14.15 - $17.19 $17,531 - $21,298
1,239 Added 3.13%
40,857 $632,000
Q3 2020

Nov 09, 2020

SELL
$14.14 - $19.71 $10,265 - $14,309
-726 Reduced 1.8%
39,618 $578,000
Q2 2020

Aug 10, 2020

BUY
$16.6 - $25.25 $63,030 - $95,874
3,797 Added 10.39%
40,344 $726,000
Q1 2020

May 15, 2020

BUY
$14.38 - $27.72 $36,899 - $71,129
2,566 Added 7.55%
36,547 $702,000
Q4 2019

Feb 14, 2020

SELL
$9.23 - $19.67 $16,881 - $35,976
-1,829 Reduced 5.11%
33,981 $651,000
Q3 2019

Nov 12, 2019

SELL
$5.66 - $11.85 $826 - $1,730
-146 Reduced 0.41%
35,810 $352,000
Q2 2019

Aug 14, 2019

BUY
$4.32 - $6.43 $15,076 - $22,440
3,490 Added 10.75%
35,956 $215,000
Q1 2019

May 13, 2019

BUY
$4.12 - $10.25 $8,936 - $22,232
2,169 Added 7.16%
32,466 $190,000
Q4 2018

Feb 14, 2019

SELL
$8.2 - $16.95 $6,133 - $12,678
-748 Reduced 2.41%
30,297 $284,000
Q3 2018

Nov 14, 2018

SELL
$17.03 - $21.18 $70,146 - $87,240
-4,119 Reduced 11.71%
31,045 $529,000
Q2 2018

Aug 14, 2018

BUY
$12.0 - $19.88 $110,820 - $183,591
9,235 Added 35.62%
35,164 $598,000
Q1 2018

May 15, 2018

SELL
$9.92 - $17.25 $7,936 - $13,800
-800 Reduced 2.99%
25,929 $348,000
Q4 2017

Feb 08, 2018

BUY
$9.15 - $11.99 $5,901 - $7,733
645 Added 2.47%
26,729 $256,000
Q3 2017

Nov 14, 2017

BUY
$8.15 - $11.16 $212,584 - $291,097
26,084
26,084 $287,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.